Since the description of anti-neutrophil cytoplasm antibodies (ANCA) in active Wegener's granulomatosis,' the interest in anti-granulocyte antibodies has increased vastly. ANCA is now recognised as a family of autoantibodies directed against cytoplasmic antigens, mainly lysosomal enzymes, in polymorphonuclear neutrophil leukocytes (PMNL).2 In Wegener's granulomatosis, ANCA are typically directed against proteinase 3, a serine proteinase located in azurophilic granules of human PMNL.3 Antiproteinase 3 antibodies may also occur in isolated, rapidly progressive glomerulonephritis and occasionally in systemic vasculitic conditions other than Wegener's granulomatosis.2 Antibodies directed against other lysosomal enzymes in PMNL azurophilic granules, for example myeloperoxidase and elastase, also occur in primary systemic vasculitic diseases and rapidly progressive glomerulonephritis.34 After ethanol fixation of PMNL, proteinase 3 remains within the cytoplasmic granules, whereas myeloperoxidase and elastase become extracted and locate close to or on the cell nucleus. 24 At indirect immunofluorescent microscopical determination of ANCA, anti-proteinase 3 antibodies produce a typical pancytoplasmatic granular staining pattern (C-ANCA), whereas antimyeloperoxidase and anti-elastase antibodies give rise to a blurry perinuclear staining pattern (P-ANCA) or staining of the PMNL nuclei (granulocyte specific anti-nuclear antibodies, GS-ANA).24' A detergent extract of isolated azurophil granules (a antigen)-can be used for the detection of anti-proteinase 3 antibodies (C-ANCA) by means of enzyme linked immunosorbent assay (ELISA) but does not allow detection of anti-myeloperoxidase.5 6 Also, antibodies against lactoferrin, an iron binding protein residing in specific granules of PNML,7 produce a P-ANCA pattern owing to perinuclear/nuclear localisation of lactoferrin after ethanol fixation. 8 Apart from the artifactual GS-ANA staining pattern caused by antibodies directed against nucleophilic cytoplasmic antigens, it is possible that true GS-ANAs also exist. 9 Apart from the occurrence in primary systemic vasculitides and rapidly progressive glomerulonephritis, P-ANCA/GS-ANA may be seen in other disease states, for example rheumatoid arthritis without signs of vasculitis,'0 inflammatory bowel disease, and primary sclerosing cholangitis."-'5 Recent evidence favours the idea that inflammatory bowel disease may be caused by mesenteric vasculitis. I'l8
In a preliminary study of 16 frozen sera from patients with Crohn's disease we found low levels of anti-a antigen antibodies, anti-myeloperoxidase antibodies, and anti-lactoferrin antibodies in some sera.'9 The present study was done to extend these observations and to include sera from patients with ulcerative colitis and primary sclerosing cholangitis. 24) , and primary sclerosing cholangitis (n=12). IgA autoantibody tests were done on sera from 51 patients with Crohn's disease, 21 ulcerative colitis sera, and 11 sera from patients with primary sclerosing cholangitis. IgG anti-bovine lactoferrin antibodies were measured essentially as described above, except that no negative or positive serum references were used. OD values were read after 30 (Fig 2) .
One patient originally included in the study had acute colitis and a high level of IgG antilactoferrin at the first sampling occasion, and a further raised anti-lactoferrin level in a later serum sample (not illustrated). This patient was, however, excluded from the study since her symptoms were explained by infection with Campylobacterjejuni. Figure 3 illustrates the lack of correlation between levels of IgG anti-human lactoferrin and
IgG anti-bovine lactoferrin as tested by ELISA with 10 sera positive in the anti-human lactoferrin and 12 sera negative in the same test. Figure 4 shows the occurrence of IgA antibodies directed against a antigen, myeloperoxidase, and human lactoferrin.
Raised levels of IgA anti-a antigen were seen in 12 of 51 (24%) sera from Crohn's disease (p<0-001), in 5 of 11 (45%) sera from patients with primary sclerosing cholangitis (p<0001), but in only 2 of 21 (10%) sera from patients with ulcerative colitis (NS). The levels of IgA antimyeloperoxidase did not differ from the control group in any of the disease states, whereas IgA anti-lactoferrin was significantly (p<005) more common in Crohn's disease, although it was seen only in a minority of the patient sera (5 of 51 = 10%). IgA anti-lactoferrin was found in significantly (p<0-001) increased frequency also in ulcerative colitis (7 of 21=33%), but not in sclerosing cholangitis (1 of 11=9%).
The levels of IgA-ANCAs were not explained by the occurrence of agglutinating rheumatoid factors (not illustrated). Figure 5 There was no obvious correlation between disease activity or extraintestinal disease (arthritis, arthralgia, skin involvement) and the presence of IgG or IgA anti-granulocyte antibodies. The levels of IgG and IgA antigranulocyte antibodies did not correlate to the total serum levels of IgG and IgA (not illustrated). Figure 6 shows the GS-ANA/P-ANCA immunofluorescence pattern of cytocentrifuged ethanol-fixed human polymorphonuclear neutrophil granulocytes after staining with rabbit anti-human milk lactoferrin. This, taken together with the western blot analysis (Fig 2) , shows that antibodies against human milk lactoferrin recognise human leukocyte lactoferrin and vice versa.
Discussion
In this study we report high frequencies of IgG anti-lactoferrin antibodies (corresponding to P-ANCA) in sera from patients with ulcerative colitis and primary sclerosing cholangitis. In Crohn's disease, however, serum anti-lactoferrin antibodies of IgG were rarely detected, and then only in patients with colonic disease manifestations. IgA anti-lactoferrin antibodies were, however, found in some cases of both ulcerative colitis and Crohn's disease.
Several different types of autoantibodies have been described in inflammatory bowel disease and primary sclerosing cholangitis." - Although none of the autoantibodies have been proved to be of pathogenetic significance, it has been shown, both in Crohn's disease and in ulcerative colitis, that IgG and complement can be present on the apical surface of enterocytes in vivo,2 29 possibly indicating a pathogenetic role for anti-epithelial/anti-brush border antibodies in inflammatory bowel disease. In this connection, and considering the high frequency of antilactoferrin antibodies found in the present study, it is interesting to note that lactoferrin has been reported to bind to intestinal brush border via a specific receptor.30 Antibodies of IgA class directed against Saccharomyces cerviciae are common in Crohn's disease but not in ulcerative colitis, and determination of such antibodies may be of diagnostic help.3" It is possible that many of the anti-microbial antibodies described in inflammatory bowel disease and other inflammatory disease states, may in fact be reflections of immunisation against microbial heat-shock proteins, which has been implied in the pathogenesis of several autoimmune disease states32 and which may induce anti-lactoferrin antibodies22 (see below).
Wakefield et al presented evidence that vasculitis and microthrombosis in mesenteric vessels can be important pathogenetic factors in inflammatory bowel disease.' '8 Furthermore, P-ANCA/GS-ANA, which occurs in several primary vasculitis diseases, can frequently be demonstrated in inflammatory bowel disease and primary sclerosing cholangitis also."-'5 P-ANCA /GS-ANA is more common in ulcerative colitis than in Crohn's disease," 13-'5 which is confirmed in the present study by the 
